Cosmo Pharmaceuticals N.V. provided earnings guidance for the year 2022. For the year, the company expects Total revenues in the range of €90 million to €100 million against €65.1 million in 2021. Operating profit in the range of €20 million to €25 million against €7 million to €10 million in 2021.